Page last updated: 2024-08-23

phosphotyrosine and pazopanib

phosphotyrosine has been researched along with pazopanib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boloor, A; Cheung, M; Crosby, RM; Crouthamel, MC; Epperly, AH; Gilmer, TM; Harrington, LE; Hopper, TM; Johnson, JH; Knick, VB; Kumar, R; Luttrell, DK; Miller, CG; Mullin, RJ; Onori, JA; Rudolph, SK; Stafford, JA; Truesdale, AT	1

Other Studies

1 other study(ies) available for phosphotyrosine and pazopanib

Article	Year
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Molecular cancer therapeutics, 2007, Volume: 6, Issue:7 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell-Free System; Cornea; Dose-Response Relationship, Drug; Female; Fibroblast Growth Factor 2; Humans; Indazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Sulfones; Vascular Endothelial Growth Factor A	2007

Article

Year

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Molecular cancer therapeutics, 2007, Volume: 6, Issue:7

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell-Free System; Cornea; Dose-Response Relationship, Drug; Female; Fibroblast Growth Factor 2; Humans; Indazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Sulfones; Vascular Endothelial Growth Factor A

2007